ANCA, first described in small-vessel vasculitis such as Wegener's granulomatosis 5 and microscopic polyangiitis, 6 have proved useful markers of disease activity. 7 Two We studied the usefulness of monitoring antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versusantibody-staining patterns using indirect immmunofluorescence (IIF) on normal neutrophils have been described: host disease (cGVHD), a major complication of allogeneic bone marrow transplantation. Antigen-specific a cytoplasmic pattern (or c-ANCA) by antibodies directed against proteinase-3 (PR3), 8 and a perinuclear pattern (or ELISA and indirect immunofluorescence (IIF) were used to search for ANCA in 47 allogeneic bone marrow p-ANCA) by antibodies directed mainly against myeloperoxidase (MPO), 6 but also against lactoferrin (LF) 9 and graft recipients who developed cGVHD and in 43 who did not (controls). Eight patients exhibited ANCA IIF elastase (HLE). 10 Our purpose was to confirm the presence of ANCA and test their usefulness during cGVHD after positivity in the cGVHD group, but none in the controls. Specificity was confirmed in antigen-specific assays in allogeneic BMT. only two cGVHD patients, both showing antilactoferrin (anti-LF) activity. One of these patients was followedMaterials and methods up, and antilactoferrin antibodies were found only at the time of active but limited cGVHD. Among three Patients ANCA IIF-positive patients, two had antinuclear autoForty-seven patients developed cGVHD after receiving an antibodies and three antineutrophil alloantibodies secallogeneic BMT in Nantes and Toulouse Clinical Hematolondary to blood transfusion, which may have been ogy Departments. The main clinical characteristics of these responsible for false ANCA IIF positivity. It is conpatients are summarized in Table 1 . Twenty-one patients cluded that ANCA determination is not useful in exhibited limited cGVHD and 26 extensive cGVHD patients with cGVHD. Polyclonal activation of B lymaccording to Shulman's classification. 11 The course of phocytes could result in ANCA activity during cGVHD. cGVHD was favorable for 34 patients and persisted at the False-positive ANCA could be due to allo-immunization time of evaluation for six patients. Seven patients died: five following blood transfusion. Rare patients may present from infection, one from veno-occlusive disease, and one antilactoferrin antibodies of unknown clinical after malignant disease relapse. significance.
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A control group of 43 patients who received an alloKeywords: allogeneic BMT; GVHD; ANCA; lactogeneic BMT without cGVHD was also tested. ferrin; vasculitis
Serum collection
Sera were harvested at an active phase of the disease for Human chronic graft-versus-host disease (cGVHD), an all patients and during follow-up whenever possible. autoimmune response by donor T cells against host alloantigens, remains a major complication following allogeneic bone marrow transplantation (BMT). 1 cGVHD Screening for IgG ANCA is characterized by a systemic, multi-organ syndrome Indirect immunofluorescence (IIF) was performed as preresembling auto-immune diseases, 2 with the presence of viously described. 12 Sera containing p-ANCA were also various circulating auto-antibodies. 3 Histologic features tested for antinuclear activity (ANA) on HEp2 cells include small-vessel vasculitis with mononuclear cell (Immunoconcept, Sacramento, CA, USA). When ANCA inflammatory infiltrate. activity was found, IIF was repeated using sera collected A preliminary study reported the presence of anti-neutrobefore transplantation. phil cytoplasmic antibodies (ANCA) during cGVHD 4 and suggested that they could be markers of disease activity.
Antigen-specific ELISA sera.
Antimyeloperoxidase (anti-MPO) activity was sought by 4th month and 29% the 6th month after BMT; and in LF ELISA: 100% the 4th and 6th months after BMT (positivity ELISA using the reference commercial MPO-purified preparation (Calbiochem, La Jolla, CA, USA) diluted 0.5 g/ml over 15%). No reactivity was found before transplantation and until the onset of cGVHD 3 months after BMT. Reacin borate-buffered saline (BBS). Briefly, after coating MPO, non-specific binding sites were blocked and sera tivity to MPO and LF decreased progressively 6 months after BMT, at the time of cGVHD resolution ( Figure 1 ). incubated, diluted 1:50 as previously described. 13 The detection system was an alkaline phosphatase-conjugated Patient 29 exhibited 100% binding in anti-LF ELISA at the time of active extensive cGVHD. No sera were goat antihuman IgG polyclonal reagent (Sigma A3150) diluted 1:1000 before addition of substrate (Sigma 104).
available at follow-up. Western blot studies showed that the sera of patients 16 Antilactoferrin (anti-LF) activity was sought by ELISA, using LF (Sigma, L0520) diluted to 1 g/ml in BBS, with and 29 reacted against LF at 78 kDa but not MPO at 120 kDa ( Figure 2 ). detection of binding as above. 9 Anti-PR3 antibodies were sought by an ␣ granule ELISA method according to
No activity was found in antigen-specific ELISA for patients with inactive cGVHD and for the control group. Rasmussen et al, 14 as well as by a commercially available anti-PR3 specific ELISA kit (IBL, Hamburg, Germany), according to the manufacturer's instructions. Anti-elastase
Antineutrophil alloantibodies (anti-HLE) activity was sought for by ELISA using HLE (Calbiochem, 324681) 10 diluted to 1 mg/ml in PBS. All three patients (4, 21 and 22) who exhibited ANCA IIF positivity but no activity in antigen-specific ELISA were For all antigen-specific ELISA tests, results are expressed as the percentage of binding of a laboratory referpositive on antineutrophil alloantibody assays. ence positive control using linear regression analysis. Positivity was defined as an absorbance greater than three standard deviations over the mean binding of a panel of 12 Discussion normal blood donor sera.
For patient 16, kinetic studies using MPO and LF ELISA Among 47 allogeneic bone marrow graft recipients who developed cGVHD in Nantes and Toulouse, eight exhibited tests were performed on nine sera collected before BMT and during the course of cGVHD.
binding in ANCA IIF at the time of active or inactive cGVHD. ANCA positivity was confirmed by antigen-MPO and LF Western blot studies were performed as previously described. 9 specific assays in only two active cGVHD patients with specificity for LF and false anti-MPO reactivity on ELISA revealed by Western blot analysis, as previously described. 9 
Antineutrophil alloantibodies
In one of these patients with limited cGVHD, anti-LF activity correlated with disease activity. The other anti-LFAntineutrophil alloantibodies were sought in three of six positive patient had active extensive cGVHD and no serum ANCA IIF-positive sera with unknown antigen specificity, available at follow-up. using a previously described technique. 15 In the six remaining patients exhibiting positive ANCA
Results

IIF studies and clinical presentation
Five patients (4, 21, 22, 29 and 31) exhibited weak positive cytoplasmic fluorescence. However, patients 4 and 22 (as well as 6) also presented antinuclear activity on HEp2 cells. One patient (16) exhibited a perinuclear and cytoplasmic pattern with no binding on HEp2 cells. Two patients (30 and 32) had p-ANCA. IIF were negative in these patients before transplantation, and in all patients after resolution of cGVHD.
Four patients (4, 30, 31 and 32) developed extensive cGVHD, and four (16, 21, 22 and 29) had limited cGVHD. Only one patient (30) had active cGVHD at follow-up.
Six patients had detectable ANCA positivity at the time of active cGVHD, and two after cGVHD was controlled or cured.
No ANCA IIF positivity was found in the control group. IIF, no binding was observed in antigen-specific assays. 4 showed dermatomyositis, patient 6 severe myositis, and Three of these patients (4, 21 and 22) were tested for ANA patient 22 minor skin lesions. The pathological significance as well as antineutrophil alloantibody activity. Two of the of these auto-antibodies remains unclear since their presthree sera exhibited antinuclear activity on HEp2 cells, ence has been reported in similar proportions after BMT which may have been responsible for false ANCA-positive without cGVHD. IIF. 6 All three sera had antineutrophil alloantibody activity, We conclude that ANCAs directed at lactoferrin are which can give false ANCA IIF positivity after blood transrarely found in chronic graft-versus-host disease after fusions, as previously reported. 16 Indeed, all these bone allogeneic bone marrow transplantation. False ANCA IIF marrow graft recipients required several blood transfusions positivity may be related to ANA or anti-neutrophil because of aplasia after chemotherapy, which cast doubt alloantibody activity. Screening for ANCA in cGVHD does upon the specificity of ANCA IIF activity. not appear to be clinically useful. Other circulating auto-antibodies have been found during cGVHD. 3 In our study, antinuclear antibodies with a nucleolar pattern were found in patients 4, 6 and 22. Patient
